Skip to main content
. 2015 Dec 18;9(12):e0004299. doi: 10.1371/journal.pntd.0004299

Table 1. Specific binding partners of the Oxaborole-Resin revealed by proteomic profiling.

GeneDB IDs Product Function Ligand competition Resin comparison
Log2 H/L Log2 H/L
Tb927.9.6870* RNA-binding protein, putative (RBSR1) Possible pre-mRNA splicing -5.68 -2.98
Tb927.10.3200* U2 splicing auxiliary factor, putative (U2AF35) pre-mRNA splicing -5.06 -2.53
Tb927.8.3060* cytosolic leucyl aminopeptidase, putative,metallo-peptidase, Clan MF, Family M17 proteolysis -4.68 -2.70
Tb927.8.4810 prohibitin 1 (PHB1) mitochondrial biogenesis -3.64 -3.57
Tb927.10.2890*; Tb11.v5.0650 enolase glycolysis -3.54 -2.57
enolase, putative
Tb927.9.8720 fructose-1,6-bisphosphatase (FBPase) gluconeogenesis -3.52 -3.22
Tb927.6.1570* 2-hydroxy-3-oxopropionate reductase, putative valine, leucine and isoleucine degradation -3.14 -2.77
Tb927.11.11250 cytosolic malate dehydrogenase (cMDH) glycolysis -2.98 -2.26
Tb927.4.2080* C2 domain containing protein (CC2D) flagellum biosynthesis -2.96 -2.29
Tb927.6.4280*; Tb927.6.4300 glyceraldehyde 3-phosphate dehydrogenase, glycosomal (GAPDH) glycolysis -2.90 -2.59
Tb927.11.11680* 2-oxoglutarate dehydrogenase E2 component, putative tricarboxylic acid cycle -2.79 -2.51
Tb927.4.1890 hypothetical protein, conserved -2.55 -2.02
Tb927.7.1310* hypothetical protein, conserved -2.42 -2.21

*Abnormal RIT-SEQ growth phenotype in bloodstream forms at either day 3 or day 6 or both [39].